cyclo(prolylglycyl) has been researched along with glycyl-prolyl-glutamic acid in 1 studies
| Studies (cyclo(prolylglycyl)) | Trials (cyclo(prolylglycyl)) | Recent Studies (post-2010) (cyclo(prolylglycyl)) | Studies (glycyl-prolyl-glutamic acid) | Trials (glycyl-prolyl-glutamic acid) | Recent Studies (post-2010) (glycyl-prolyl-glutamic acid) |
|---|---|---|---|---|---|
| 48 | 0 | 28 | 43 | 0 | 13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguado-Llera, D; Argente, J; Arilla-Ferreiro, E; Barrios, V; Canelles, S; Fernández-Mendívil, C; Frago, LM; López, MG | 1 |
1 other study(ies) available for cyclo(prolylglycyl) and glycyl-prolyl-glutamic acid
| Article | Year |
|---|---|
Improvement in inflammation is associated with the protective effect of Gly-Pro-Glu and cycloprolylglycine against Aβ-induced depletion of the hippocampal somatostatinergic system.
Topics: Amyloid beta-Peptides; Animals; Cell Death; Female; Hippocampus; Inflammation; Neurons; Neuroprotective Agents; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Phosphorylation; Rats; Rats, Wistar; Receptors, Somatostatin; Signal Transduction; Somatostatin | 2019 |